Latest Breaking News On - வில்சன் பில் வாக்கர் - Page 1 : comparemela.com

4D pharma plc: 4D Pharma to Present at Upcoming Investor Conferences in March 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) a novel class of drug derived from the microbiome, today announced that 4D management will present at three upcoming investor conferences: Chardan s Virtual 3rd Annual Microbiome Medicines Summit: Monday March 8, 2021 at 11:45 am ET (16:45 GMT). H.C. Wainwright Global Life Sciences Conference: Available on-demand starting Tuesday, March 9, 2021 at 7:00 am ET (12:00 GMT). Oppenheimer s 31 About 4D pharma Founded in February 2014, 4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx, that rationally identifies Live Biotherap

United-states
Julie-seidel
Dominic-wilson-phil-walker
Neil-hunter-michelle-boxall
Bryan-garnier-co
Stern-investor-relations-inc
Image-box-communications
Nasdaq
Exchange-commission
Merck-co-inc
United-states-securities-exchange
Longevity-acquisition-corporation